<DOC>
	<DOC>NCT02208596</DOC>
	<brief_summary>To explore the feasibility of different doses of etomidate admixed with propofol in induced abortion: a randomized, double blind controlled trial.</brief_summary>
	<brief_title>The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<mesh_term>Pentazocine</mesh_term>
	<criteria>Aged between 20 and 35 years American Society of Anesthesiology (ASA) Physical Status: Ⅰ or Ⅱ Singleton pregnancy and the gestational period is 6 to 8 weeks Expected operation duration is within 60 minutes The body weight should be within 15% around the standard weight Signed informed consent form Serious cardiac, cerebral, liver, kidney, lung, endocrine disease Upper respiratory infections within 4 weeks Long use of hormone or history of adrenal suppression History of use of glucocorticoids, aprotinin or immunosuppressant Manifestation of immunodeficiency History of use of sedatives or opiates Needs of Neuromuscular blocker (except intubation) Allergy to trial drug or other contraindication Pregnant or breastfeeding women Attended other trial past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>